COEXPRESSION OF EPITHELIAL-MESENCHYMAL TRANSITION TWIST2 ONCOGENE AND SCHISTOSOMAL ANTIGEN REACTIVITY MARKER IN MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF URINARY BLADDER PERDICT LY

Clinico-pathological Features of Squamous Cell Carcinoma of Urinary Bladder at South Egypt Cancer Institute (Retrospective Study)

HISTOPATHOLOGICAL ANALYSIS OF SCHISTOSOMA HAEMATOBIUM METAPLASIA OF THE URINARY BLADDER

CD44 and p53 co-expression in high grade, muscle invasive bladder urothelial carcinoma with and without schistosomiasis

TWIST2 EXPRESSIONS IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE URINARY BLADDER SHOWED DOWN REGULATION CORRELATED WITH GOOD SURVIVAL AND LOW INCIDENCE OF DISTANT METASTASIS

IMMUNOHISTOCHEMICAL EXPRESSION OF P16 IN CERVICAL AND URINARY BLADDER SQUAMOUS CELL CARCINOMA

UROTHELIAL CARCINOMA OF THE URINARY BLADDER MIXED WITH SQUAMOUS DIFFERENTIATION OR SQUAMOUS CELL CARCINOMA IN AREAS WITH SCHISTOSOMIASIS IS SHOWING HIGH RISK OF RECURRENCE AND PO

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

EXPRESSION OF CYTOKERATIN 7, 20, 14 IN UROTHELIAL CARCINOMA AND SQUAMOUS CELL CARCINOMA OF THE EGYPRIAN URINARY BLADDER CANCER

Immunohistochemical Expression of HER2/NEU and CD10 in Urothelial Carcinoma of Urinary Bladder